City
Epaper

Long queue outside vaccination centres after Delhi commences inoculation for people b/w 18-44 years

By ANI | Updated: May 3, 2021 11:25 IST

As Delhi starts vaccination for the beneficiaries between 18-44 years, the long queues can be seen outside various vaccination centres in the national capital.

Open in App

As Delhi starts vaccination for the beneficiaries between 18-44 years, the long queues can be seen outside various vaccination centres in the national capital.

Pre-registration is mandatory for beneficiaries in the 18-45 age group and there is no walk-in facility for this category.

"COVID vaccination is important citing the present situation. Vaccination can reduce the death tendency," said Shruti, a beneficiary waiting for his term to get vaccinated at a vaccination centre in Ashok Nagar area.

Another beneficiary Mithun toldthat he was waiting for long time for the government to open a window for the vaccination for the 18-45 age group.

"I am excited to get myself vaccinated against COVID-19. Vaccination is important as the cases in the country are rising," he added.

"I registered myself yesterday only and got the appointment today. This is good," Pavan, another beneficiary waiting to himself vaccinated said.

Delhi Chief Minister Arvind Kejriwal on Saturday had announced that the vaccination for the people aged between 18-44 years will be vaccinated from May 3 while the vaccination for the same was started across the country on May 1.

The country had started the COVID-19 vaccination drive on January 16 with two vaccines -- Covishield (Oxford-AstraZeneca's vaccine manufactured by Serum Institute of India) and Covaxin (manufactured by Bharat Biotech Limited).

As many as 77 government schools in the national capital are serving as COVID-19 vaccination centres for people between 18-44 years.

Delhi recorded 20,394 new COVID-19 cases and 407 deaths on Sunday.

As per the official data issued on Sunday, the total count of cases in the city has gone up to 11,94,946 including 92,290 active cases and 10,85,690 recoveries. The death toll has gone up to 16,966.

Meanwhile, the lockdown in the national capital has been extended till May 10.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Bharat BiotechArvind KejriwalSerum Institute Of IndiaSerum institute of india pvt. ltdSerum india
Open in App

Related Stories

NationalIf He Goes To Jail... BJP MLA Tarvinder Singh Marwah Blames Arvind Kejriwal for Delhi's Corruption and COVID-19 Deaths

NationalNew Delhi CM Swearing-In: Grand Preparations Underway for Oath Ceremony at Ram Leela Maidan (Watch Video)

NationalMCD Mayoral Election: Setback for Arvind Kejriwal As 3 AAP Councillors Join BJP Ahead of Polls

NationalArvind Kejriwal’s 'Sheesh Mahal' Under CVC Probe for Alleged Renovation Violations

NationalArvind Kejriwal to Receive No Salary or Government Bungalow; Here’s the Pension and Facilities He Will Get After Delhi Election Defeat

National Realted Stories

NationalLifted ban on issuance of EWS certificates, Delhi govt tells HC

NationalPunjab Police attain 89 pc conviction rate in NDPS cases, says DGP Yadav

NationalCentre rolls out projects to boost fisheries in 7 coastal states

NationalBuoyed by huge turnout at public meeting, BRS confident of returning to power

NationalJabalpur’s newborn gets life-saving heart treatment under Rashtriya Bal Swasthya Karyakram